Advertisement

Topics

EraGen Biosciences Incorporated Company Profile

16:19 EDT 21st September 2018 | BioPortfolio

EraGen Biosciences, Inc., develops novel genomic and bioinformatics licensing technologies for nucleic acid diagnostics, drug design and drug discovery. We have established a broad patent estate in the areas of bioinformatics, DNA diagnostics, pharmacogenomics and combinatorial chemistry. From this developed knowledge base, EraGen has created a number of innovative tools including high-throughput genotyping assays and the MasterCatalog™ bioinformatics platform. Our core scientific knowledge and proprietary developments places EraGen in a unique position to design advanced technologies for medical, pharmaceutical and research use.

EraGen, along with clients and collaborators, is working to deploy the next generation of genomic tools that will enable accelerated discovery of new diagnostics and drugs. Our employees, including world-renowned scientists, software engineers, and management professionals, continue to develop the core integrated suite of genomics technologies for improving health.

Location

918 Deming Way
Madison
Wisconsin
53717-1910
United States of America

Contact

Phone: 608 662 9000
Fax: 608 662 9003
Email: info@eragen.com


News Articles [667 Associated News Articles listed on BioPortfolio]

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women...

Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that ...

Kaskela Law LLC: IMPORTANT SHAREHOLDER DEADLINE ALERT: Solid Biosciences, Inc. - SLDB

RADNOR, PA / ACCESSWIRE / May 23, 2018 / Kaskela Law LLC reminds Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") investors that a class action complaint has been filed...

SOLID BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF ...

Solid Biosciences investors should visit us at https://www.claimsfiler.com/cases/view-solid-biosciences-inc-securities-litigationor call to speak to our claim center toll-free at (844) 367-9658.   ...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer

Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer Schlieren (Zurich), Switzerland, August 23, 2018 Kuros Biosciences AG (SIX: KURN) announced today the appointment of Pascal Long...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-SA01, for patients with serious or immediately life-threatening Staphyl...

Companies [400 Associated Companies listed on BioPortfolio]

EraGen Biosciences Inc.

EraGen Biosciences develops, manufactures and markets innovative molecular diagnostic products that are driving a new era in clinical diagnostics and research. The company’s ...

EraGen Biosciences Incorporated

EraGen Biosciences, Inc., develops novel genomic and bioinformatics licensing technologies for nucleic acid diagnostics, drug design and drug discovery. We have established a broad patent estate in th...

EraGen Biosciences

EraGen products drive diagnostics and drugs to market faster by providing clinical laboratory and drug discovery researchers a high level of accuracy and efficiency. The synergy of our innovative and ...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

More Information about "EraGen Biosciences Incorporated" on BioPortfolio

We have published hundreds of EraGen Biosciences Incorporated news stories on BioPortfolio along with dozens of EraGen Biosciences Incorporated Clinical Trials and PubMed Articles about EraGen Biosciences Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EraGen Biosciences Incorporated Companies in our database. You can also find out about relevant EraGen Biosciences Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record